Does EMTRICITABINE Cause Viral mutation identified? 161 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 161 reports of Viral mutation identified have been filed in association with EMTRICITABINE (Truvada). This represents 4.3% of all adverse event reports for EMTRICITABINE.
161
Reports of Viral mutation identified with EMTRICITABINE
4.3%
of all EMTRICITABINE reports
2
Deaths
6
Hospitalizations
How Dangerous Is Viral mutation identified From EMTRICITABINE?
Of the 161 reports, 2 (1.2%) resulted in death, 6 (3.7%) required hospitalization.
Is Viral mutation identified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMTRICITABINE. However, 161 reports have been filed with the FAERS database.
What Other Side Effects Does EMTRICITABINE Cause?
Foetal exposure during pregnancy (609)
Drug resistance (370)
Virologic failure (331)
Immune reconstitution inflammatory syndrome (262)
Exposure during pregnancy (212)
Drug ineffective (196)
Pathogen resistance (166)
Maternal exposure during pregnancy (160)
Death (154)
Treatment noncompliance (136)
What Other Drugs Cause Viral mutation identified?
LAMIVUDINE (1,631)
TENOFOVIR DISOPROXIL (730)
EFAVIRENZ (641)
ZIDOVUDINE (531)
NEVIRAPINE (518)
DOLUTEGRAVIR (510)
ABACAVIR (378)
RALTEGRAVIR (284)
STAVUDINE (258)
RITONAVIR (228)
Which EMTRICITABINE Alternatives Have Lower Viral mutation identified Risk?
EMTRICITABINE vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE
EMTRICITABINE vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL
EMTRICITABINE vs EMTRICITABINE\TENOFOVIR
EMTRICITABINE vs EMTRICITABINE\TENOFOVIR ALAFENAMIDE
EMTRICITABINE vs EMTRICITABINE/TENOFOVIR DISOPROXIL